Caxton Associates LP Care Dx, Inc. Transaction History

Caxton Associates LP

$2.65 Billion
Q3 2024

A detailed history of Caxton Associates LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 36,280 shares of CDNA stock, worth $811,583. This represents 0.04% of its overall portfolio holdings.

Number of Shares

36,280

Holding current value

$811,583

% of portfolio

0.04%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$14.41 - $33.99 $522,794 - $1.23 Million	36,280 New	36,280 $1.13 Million
Q1 2024 May 15, 2024	BUY	$7.96 - $12.37 $377,853 - $587,191	47,469 Added 97.19%	96,308 $1.02 Million
Q3 2023 Nov 14, 2023	BUY	$7.0 - $11.26 $147,735 - $237,642	21,105 Added 76.1%	48,839 $341,000
Q2 2023 Aug 14, 2023	BUY	$7.61 - $9.46 $211,055 - $262,363	27,734 New	27,734 $235,000
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $276,314 - $339,487	-8,948 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$18.95 - $35.43 $169,564 - $317,027	8,948 New	8,948 $317,000
Q4 2018 Feb 14, 2019	SELL	$19.89 - $30.02 $138,533 - $209,089	-6,965 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.1 - $28.85 $84,276 - $200,940	6,965 New	6,965 $201,000

Others Institutions Holding CDNA

# of Institutions

219

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

Black Rock Inc. New York, NY

5.29M
Shares

$118 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.54M
Shares

$101 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.15M
Shares

$70.4 Million
1.65% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.99M
Shares

$66.9 Million
0.89% of portfolio
State Street Corp Boston, MA

2.04M
Shares

$45.5 Million
0.0% of portfolio

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.2B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account